William Makis MD engagement report
@MakisMedicine - 697K followers on X
Measured over 40 original posts from a 30-day window, last computed on October 3, 2026.
Engagement
A typical post picks up 1.2K interactions against 697K followers, an engagement rate of 0.173%. Measured over 40 original posts, its engagement rate beats 79% of 21,624 tracked accounts of a similar size. Comparing inside a size band matters here: engagement rate falls as accounts grow, so a raw rate would mostly just re-measure the follower count. Posts are seen about 47K times each, and 2.55% of those impressions turn into an interaction. That is about 6.70% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 4 posts a day over the last 30 days, with activity on almost every day in the window. Most posts go out around 18:00 UTC, and Friday is the busiest day of the week. Of the 40 posts sampled, 78% carry an image or video, 10% are part of a thread and 20% link out. The account's strongest tracked post pulled 234K interactions, about 196x its own typical post. Recurring topics include #antivaxxers, #covidvaccine.
Measured over 40 original posts from a 30-day window, last computed on October 3, 2026. Recurring tags: #antivaxxers, #covidvaccine.
Compared with accounts its own size
William Makis MD's engagement rate beats 79% of the tracked X accounts closest to it in follower count (21,624 accounts, accounts of similar size (decile 10 of 10)). A percentile is spread evenly by construction, so 50 really is the middle of that group and 90 really is its top tenth.
On engagement per impression rather than per follower it beats 73% of the same group. When those two numbers disagree, the gap is about how far its posts travel rather than how people react to them.
Where this sits in the catalog
At 0.173%, William Makis MD sits above the 50th percentile of the 218,727 accounts in this comparison. That places it in the above the median band, which runs 0.149% to 0.706%.
Show the percentile table
| Percentile | Engagement rate |
|---|---|
| 10th percentile | 0.004% |
| 25th percentile | 0.025% |
| 50th percentile | 0.149% |
| 75th percentile | 0.706% |
| 90th percentile | 2.63% |
| 99th percentile | 82.5% |
This ruler is the whole measured catalog, not a size-matched group: it shows where the raw rate falls across every account we can measure, all of which are large. For a like-for-like comparison, read the size-band percentile above instead. See how the bands are built
Posting timing
This account posts most often around 18:00 UTC, and Friday is its busiest day of the week. The bars below are the catalog-wide pattern, with this account's own busiest slot marked. They do not show how this account performs at each hour: we keep one aggregate per account, not one per hour, so that measurement does not exist in our data.
Show engagement by hour posted, utc as a table
| Hour (UTC) | Vs author median | Posts |
|---|---|---|
| 00:00 UTC | -1% | 89K |
| 01:00 UTC | -2% | 90K |
| 02:00 UTC | -3% | 88K |
| 03:00 UTC | -4% | 94K |
| 04:00 UTC | -5% | 76K |
| 05:00 UTC | -4% | 75K |
| 06:00 UTC | -5% | 86K |
| 07:00 UTC | -5% | 93K |
| 08:00 UTC | -4% | 108K |
| 09:00 UTC | -4% | 124K |
| 10:00 UTC | -3% | 129K |
| 11:00 UTC | -3% | 141K |
| 12:00 UTC | -3% | 154K |
| 13:00 UTC | -3% | 167K |
| 14:00 UTC | -4% | 173K |
| 15:00 UTC | -2% | 176K |
| 16:00 UTC | -3% | 171K |
| 17:00 UTC | -3% | 159K |
| 18:00 UTC | -2% | 149K |
| 19:00 UTC | -2% | 141K |
| 20:00 UTC | -1% | 131K |
| 21:00 UTC | 0% | 116K |
| 22:00 UTC | -2% | 100K |
| 23:00 UTC | -1% | 90K |
Show engagement by day of week as a table
| Day | Vs author median | Posts |
|---|---|---|
| Sunday | +5% | 393K |
| Monday | +1% | 483K |
| Tuesday | -2% | 520K |
| Wednesday | -3% | 472K |
| Thursday | -2% | 430K |
| Friday | -3% | 447K |
| Saturday | +2% | 393K |
Formats this account uses
Its own posting mix on the left, and what each of those formats does across every account we track on the right. Only formats where the effect clears our publish test appear here, so an empty row is a format we could not measure rather than one that does nothing.
| Format | This account | Catalog effect | 95% interval | Accounts behind it |
|---|---|---|---|---|
| Image or video | 78% of posts | +111% | +108% to +115% | 34K |
| Outbound link | 20% of posts | -41% | -42% to -40% | 32K |
| Typical length | - | +15% | +14% to +16% | 32K |
- 78% of this account's sampled posts carry an image or video. Across the catalog, posts with an image or video run 111% above the same accounts' other posts.
- 20% of its posts carry a link off X. Across the catalog, posts with an outbound link run 41% below the same accounts' other posts.
- Its average post runs 854 characters, which falls in the over 280 characters band. Across the catalog, posts over 280 characters run 15% above the same accounts' other posts.
These are catalog-wide differences applied to this account's own posting mix, not a measurement of how each format performs for this account specifically. We keep one median per account, not one per format per account, so the second thing is not something this data can tell you.
Best tweets
- Jan 10, 2025196x their median
GIBSON: "I have three friends. All three of them had stage four cancer. All three of them don't have cancer right now at all." ROGAN: "What did they take?" GIBSON: "Ivermectin, Fenbendazole" https://t.co/onLx5bvDcG
- Aug 30, 202646x their median
Well that was quick. Crown Royal is pulling bottling out of Ontario. Stellantis is shutting down a car factory in Brampton and moving it to Illinois. Ford is considering moving tens of thousands of jobs from Canada to the U.S. Maybe Mark Carney and Doug Ford shouldn't have decided to hold their breath until they turned blue.
- Aug 19, 202638x their median
🚨BREAKING: The State of Florida is launching a study on Ivermectin to see if it can potentially cure cancer. This is HUGE. https://t.co/sc2p6FDCjc
- Jul 2, 202436x their median
NEW ARTICLE: IVERMECTIN - Articles and Protocols for CANCER, Research studies and access to Ivermectin pills Recently, I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. So I'm reposting my Ivermectin Cancer Protocol. It's very simple to use. Did you know that Ivermectin is annually taken by close to 250 million people? Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. That’s how it should be. I recently wrote about how a doctor in Saskatchewan, Canada was just given a $44,800 penalty by the College of Physicians and Surgeons for prescribing Ivermectin to a few patients during 2020-2022. The Ontario College of Physicians even had an Investigator go undercover and dress up as a Canadian Trucker to ensnare a young doctor prescribing Ivermectin in Ottawa in 2022 during the Trucker Convoy. Canadians must realize that the Colleges of Physicians and Surgeons are private corporations, fully bought off by big pharma and run by mafia lawyers who are putting pressure on doctors to comply or else No healthcare bureaucrat or lawyer has the right to deny anyone access to life saving medication. And if they do, they are committing a very serious crime. It's time for Canadians to bring the Colleges of Physicians and Surgeons to Justice for their many COVID-19 crimes, take them over, dissolve them, and start over. I now have a trusted, affordable source for Ivermectin, so if you need access to Ivermectin, please email me. Article Link in photo to avoid shadowban, just re-type the URL in the 1st photo at the top, into your browser to access @JoeRogan @TuckerCarlson @ABDanielleSmith #DiedSuddenly
- Aug 19, 202621x their median
“If they had a cure for cancer they wouldn’t sell it” Yes they would, because it would make them rich https://t.co/m6kQ6S09oy
- Sep 23, 202613x their median
NEWS: Update on Ivermectin in Cancer Clinical Trials in Florida 😃 There were 2 clinical trials in 2025, there are 6 clinical trials in 2026 and hopefully 10-12 clinical trials in 2027! One of them will be completed next month! Very exciting times for cancer patients! 🙏 https://t.co/CRqrdJHbKW
- Sep 27, 202610.0x their median
VIDEO: IVERMECTIN and Chemo Everything you’ve wanted to know but were afraid to ask 😃 https://t.co/YmwP2CX1kI
- Mar 2, 20266.9x their median
My brother was diagnosed w Stage 4 glioblastoma Christmas day. Well, after 2 months of strictly following the @MakisMedicine protocol, there is no evidence of any tumor. With Stage 4 glioblastoma this a huge win and we will take them where we can. Power of prayer at work too!! Don't discount repurposed meds.
- Aug 29, 20265.4x their median
BREAKING: BioNTech mRNA Cancer “Vaccine” Trial TERMINATED Over Alarming Mortality Signal --- and they won't say how bad it was. https://t.co/aXS8ROuN57
- Sep 28, 20265.1x their median
Susie Wiles @SusieWiles didn’t get Ivermectin or Mebendazole and suffered horribly from Mayo Clinic’s Stone Age, outdated chemotherapy regimen!! Completely unnecessary suffering that could have been avoided by a competent Oncologist! https://t.co/n1TYb6VqhD
Ranked by total interactions across everything we have tracked for this account, which is a longer history than the 30-day window the rates above use. The multiple compares each post to this account's own median.
Recurring topics
The most frequent hashtags in the sampled posts. They describe what this account writes about; they are not a performance signal, and the catalog-wide breakdown on the hub shows how little hashtag count moves.
Buy or sell Twitter (X) accounts - escrow-protected
PlayerSells is an escrow marketplace for Twitter (X) accounts. Every deal is protected, with no middleman risk.
Reading these numbers
A typical post picks up 1.2K interactions against 697K followers, an engagement rate of 0.173%. Measured over 40 original posts, its engagement rate beats 79% of 21,624 tracked accounts of a similar size. Comparing inside a size band matters here: engagement rate falls as accounts grow, so a raw rate would mostly just re-measure the follower count. Posts are seen about 47K times each, and 2.55% of those impressions turn into an interaction. That is about 6.70% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 4 posts a day over the last 30 days, with activity on almost every day in the window. Most posts go out around 18:00 UTC, and Friday is the busiest day of the week. Of the 40 posts sampled, 78% carry an image or video, 10% are part of a thread and 20% link out. The account's strongest tracked post pulled 234K interactions, about 196x its own typical post. Recurring topics include #antivaxxers, #covidvaccine.
- What is William Makis MD's engagement rate on X?
- William Makis MD (@MakisMedicine) has an engagement rate of 0.173%, based on the median interactions across 40 original posts from the last 30 days against 696,911 followers. Replies, reposts and quote-posts of other people are excluded from that sample.
- Is that a good engagement rate?
- At 0.173%, William Makis MD sits above the 50th percentile of the 218,727 accounts in this comparison. Those comparison accounts are all large ones, because our scanning cadence is weighted towards big accounts, so this is a ranking among peers of similar scale rather than a ranking across X.
- Does @MakisMedicine have real engagement?
- Its engagement rate beats 79% of the tracked X accounts closest to it in follower count (21,624 accounts), which puts it in the top quarter for its size group. Ranking inside a size band matters because engagement rate falls as accounts grow, so a raw rate would mostly re-measure the follower count. It is a starting point for a look at follower quality, not a verdict on it.
- When does @MakisMedicine post?
- Most posts go out around 18:00 UTC, and Friday is its busiest day, at roughly 4 posts per day across the measured window.